Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”"이버멕틴의 항바이러스 및 항염증 특성 및 Covid-19에서의 잠재적 사용"에 대한 답변Comment Published on 2020-12-012022-09-11 Journal: Monatsschr Kinderheilkd (1902) [Category] SARS, 치료제, [키워드] anti-inflammatory property Reply [DOI] 10.1016/j.arbr.2020.11.002 PMC 바로가기 [Article Type] Comment
Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19Correspondence Published on 2020-12-012022-10-05 Journal: Archivos de bronconeumología [Category] 치료제, [키워드] anti-inflammatory property Ivermectin [DOI] 10.1016/j.arbr.2020.06.006 [Article Type] Correspondence
Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in COVID-19”"이버멕틴의 항바이러스 및 항염증 특성 및 COVID-19에서의 잠재적 사용"에 대한 답변Comment Published on 2020-12-012022-09-11 Journal: Monatsschr Kinderheilkd (1902) [Category] SARS, 치료제, [키워드] anti-inflammatory property Reply [DOI] 10.1016/j.arbres.2020.09.004 PMC 바로가기 [Article Type] Comment
The Role of Vitamin C as Adjuvant Therapy in COVID-19Internal Medicine Published on 2020-11-302022-10-31 Journal: Cureus [Category] COVID-19, [키워드] adjuvant affected age anti-inflammatory property biochemical Care clinical symptom clinician conducted coronavirus disease COVID-19 COVID-19 patient Gender had no hospital Hospital stay IMPROVE Intervention intravenous vitamin C Karachi mechanical ventilation Mortality no significant difference outcome Pakistan Patient questionnaire Randomized controlled trial RCT recorded required Result role shown significantly Standard therapy therapy Treatment two group two groups Ventilation vitals Vitamin Vitamin C [DOI] 10.7759/cureus.11779 PMC 바로가기 [Article Type] Internal Medicine
A Scientific Rationale for Using Cystic Fibrosis Transmembrane Conductance Regulator Therapeutics in COVID-19 PatientsPhysiology Published on 2020-11-042022-10-31 Journal: Frontiers in Physiology [Category] COVID-19, [키워드] addition anti-inflammatory property approved arise benefit Brain cerebrovascular CFTR chronic obstructive clearance condition Conductance coronavirus disease COVID-19 COVID-19 infection COVID-19 pathogenesis COVID-19 patients Cystic cytokine disease downregulate driving dysfunction effort example fibrosis immune cell response immune cells lung Lung pathology manifestation Necrosis offer overlap Perspective promote protein expression pulmonary disease rationale regulator Safe stroke Therapeutics TNF transmembrane tumor necrosis factor [DOI] 10.3389/fphys.2020.583862 PMC 바로가기 [Article Type] Physiology
Ibuprofen, a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution분무 가능한 용액에서 COVID-19의 새로운 효과적인 제형의 과정에 영향을 미칠 수 있는 전통 약물, 이부프로펜Article Published on 2020-11-012022-09-11 Journal: Medical Hypotheses [Category] SARS, 치료제, [키워드] 2019-nCoV 2019-nCoV infection absence Actin actin protein actin proteins Administered airway airways anti-inflammatory property Bacteria Bioavailability biological property Burkholderia caused Concentration contribute coronavirus Course COVID-19 demonstrated dose duplication Effect effective enveloped virus enzyme family filament health emergency hydrosoluble hypertonic Hypothesis ibuprofen include Infection inhibit Interaction investigator involved ionic strength kill local inflammation lung Lung inflammation Lungs membrane methicillin methicillin-resistant Staphylococcus aureus mucolytic nebulized NIH Other oxygen Pathogenesis people with COVID-19 physico-chemical properties physico-chemical property prevention strategies reactive oxygen species reactive oxygen specy reduce reduced reorganization required ROS SARS-CoV-2 Spread Staphylococcus aureus systemic inflammatory response systemic inflammatory responses therapeutic therapeutic effect virucidal virus virus infection water [DOI] 10.1016/j.mehy.2020.110079 PMC 바로가기 [Article Type] Article
Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant RecipientsPediatrics Published on 2020-10-302022-10-31 Journal: Frontiers in Pediatrics [Category] COVID-19, [키워드] acute respiratory syndrome affected anti-inflammatory property antibody Assessing assessment children Cohort coronavirus coronavirus disease courses COVID-19 evaluate evaluated help higher risk IgM antibody Immunosuppressive medication kidney Kidney disease kidney transplant mechanisms nasopharyngeal Occurrence one patient pandemic Patient patient population patients PCR pediatric persistence positive recipient recipients reflect SARS-CoV-2 SARS-CoV-2 anti-spike IgG SARS-CoV-2 antibody SARS-CoV-2 disease SARS-COV-2 infection Seroconversion seroconverted serology severe COVID-19 disease severe SARS-CoV-2 social distancing solid organ transplant symptomatic Transplant Vaccine were measured [DOI] 10.3389/fped.2020.601327 PMC 바로가기 [Article Type] Pediatrics
Perspective: The Potential Effects of Naringenin in COVID-19Immunology Published on 2020-09-252022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] ACE2 acute respiratory syndrome Anti-inflammatory anti-inflammatory property Antiviral caused Chronic illness compounds Coronavirus disease 2019 COVID-19 COVID-19 case cytokine production death develop diabetes Effect higher risk hypertension include investigated multiple organ failure naringenin obesity pandemic Perspective Potential reducing respiratory risk factor SARS-CoV-2 SARS-COV-2 infection Sepsis specific treatment subject TNF Vaccine viral replication World Health Organization [DOI] 10.3389/fimmu.2020.570919 PMC 바로가기 [Article Type] Immunology
Treatment of COVID 19-Repurposing drugs commonly used in dermatology피부과에서 일반적으로 사용되는 COVID 19 - 용도 변경 약물의 치료Review Published on 2020-09-012022-08-31 Journal: Dermatologic therapy [Category] SARS, 신약개발, 치료제, [키워드] addition anti-inflammatory property Antiviral Antiviral treatment Autoimmune disease candidate caused characteristic Chloroquine clinical utility complex interplay coronavirus COVID COVID 19 COVID-19 COVID-19 pathogenesis Dermatology disease drug drugs dysregulation effective Effects focus global health Health Hydroxychloroquine immune response initiated outbreak Pathogenesis pharmacological public health recommendation Research SARS-CoV-2 severe disease Side effects therapeutic target therapeutic targets Therapies Toxicity Treatment treatment of COVID-19 Viral viral damage virus Virus Disease well [DOI] 10.1111/dth.13829 PMC 바로가기 [Article Type] Review
Beyond Anti-viral Effects of Chloroquine/HydroxychloroquineImmunology Published on 2020-07-022022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] ACE2 affected anti-inflammatory property anti-viral effect antigen processing Antiviral appear Arthritis Autoimmune diseases autophagy cellular activation Chloroquine country COVID-19 COVID-19 pandemic COVID-19 patients cytosolic decrease detrimental discrepancy Effect Efficacy explain highlight Host immune response Hydroxychloroquine in vitro Inflammation Inflammatory cytokine inflammatory process inhibit interfere interferon limit lysosomal nucleic acids Patient progression receptor remained Replication required RIG-I SARS virus SARS-CoV2 SARS-CoV2 infection secretion Signaling STING therapy TLR Toll-like receptor Treatment type I interferon virus [DOI] 10.3389/fimmu.2020.01409 PMC 바로가기 [Article Type] Immunology